Trial studying safety and effects for Acne
Official title Safety and Efficacy of Skincare Products for Managing Mild to Moderate Acne in Individuals With Sensitive Skin
ClinicalTrials.gov ID: NCT07749469
What this study is testing
- What it's testing
- To investigate the safety and efficacy of a skincare regimen in individuals with mild to moderate acne and sensitive skin. The study duration is 4 weeks and the skin assessment will be carried out at baseline and week 4.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Healthy Malaysian women and men
- Fitzpatrick skin type II-V
- Age above 18 years old
- Individuals with sensitive skin identify through sensitive skin survey (Corazza et al., 2022) and lactic acid sting test (LAST).
- Individuals with mild to moderate acne, based on Comprehensive Acne Severity Scale (CASS)
You likely can't join if
- Pregnant or breastfeeding women, or those planning pregnancy during the study period.
- Individuals with documented autoimmune diseases or other conditions that may affect immune response or skin barrier function.
- Individuals with a history of severe skin sensitivity reactions, including frequent intense erythema, swelling, or intolerable burning in response to...
- Individuals with severe acne requiring medical treatment or systemic treatment such as nodulocystic acne.
- Individuals with active inflammatory or allergic dermatological conditions affecting the face, such as atopic dermatitis, eczema, or psoriasis, which...
- Individuals who have undergone cosmetic or dermatological procedures such as -chemical peel, microneedling, or any procedures aimed at improving...
See the full eligibility criteria
- Healthy Malaysian women and men
- Fitzpatrick skin type II-V
- Age above 18 years old
- Individuals with sensitive skin identify through sensitive skin survey (Corazza et al., 2022) and lactic acid sting test (LAST).
- Individuals with mild to moderate acne, based on Comprehensive Acne Severity Scale (CASS)
- Pregnant or breastfeeding women, or those planning pregnancy during the study period.
- Individuals with documented autoimmune diseases or other conditions that may affect immune response or skin barrier function.
- Individuals with a history of severe skin sensitivity reactions, including frequent intense erythema, swelling, or intolerable burning in response to topical products.
- Individuals with severe acne requiring medical treatment or systemic treatment such as nodulocystic acne.
- Individuals with active inflammatory or allergic dermatological conditions affecting the face, such as atopic dermatitis, eczema, or psoriasis, which may compromise skin barrier function or interfere with study...
- Individuals who have undergone cosmetic or dermatological procedures such as -chemical peel, microneedling, or any procedures aimed at improving acne, within 3 months prior to the study.
- Individuals currently taking medical or hormonal treatments that may interfere with study outcomes, including anti-inflammatory agents, corticosteroids, or other medication interfering with study objectives.
- Individuals with known allergy or hypersensitivity to any ingredients found in the product.
The study team makes the final eligibility decision.
Where it's taking place
- Petaling Jaya, Selangor, Malaysia
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Petaling Jaya, Selangor, Malaysia. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.